|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07C 211/14 | (2006.01) |
| A61K 31/132 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3652145 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19724752.1 |
| Date of filing the European patent application | 2019-05-03 | |
| (97) | Date of publication of the European application | 2020-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2025-09-17 |
| (46) | Date of publication of the claims translation | 2026-01-26 |
| (86) | Number | PCT/EP2019/061441 |
| Date | 2019-05-03 |
| (87) | Number | WO 2019/211464 |
| Date | 2019-11-07 |
| (30) | Number | Date | Country code |
| 18290048 | 2018-05-04 | EP |
| (72) |
MORLEY, Timothy James , GB
LAWRENCE, Ronnie Maxwell , GB
AMIN, Naseem , GB
|
| (73) |
Orphalan S.A. ,
226 boulevard Voltaire, 75011 Paris,
FR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Trietilentetramino tetrahidrochlorido kristalinė forma ir jos farmacinis naudojimas |
| CRYSTALLINE FORM OF TRIETHYLENETETRAMINE TETRAHYDROCHLORIDE AND ITS PHARMACEUTICAL USE |
| Payment date | Validity (years) | Amount | |
| 2026-03-23 | 8 | 185.00 EUR |
| 2027-05-03 |